{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:09:15Z","timestamp":1790770155298,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":2686,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1093\/annonc\/mds187","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T20:37:26Z","timestamp":1348605446000},"page":"vi7-vi12","source":"Crossref","is-referenced-by-count":446,"special_numbering":"S6","title":["Triple-negative breast cancer: epidemiological considerations and recommendations"],"prefix":"10.1016","volume":"23","author":[{"given":"P.","family":"Boyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mds187_bb0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(06)69225-8","article-title":"The globalisation of cancer","volume":"368","author":"Boyle","year":"2006","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mds187_bb0015","series-title":"World Cancer Report 2008","author":"Boyle","year":"2008"},{"key":"10.1093\/annonc\/mds187_bb0020","doi-asserted-by":"crossref","first-page":"c3620","DOI":"10.1136\/bmj.c3620","article-title":"Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database","volume":"341","author":"Autier","year":"2010","journal-title":"Br Med J"},{"key":"10.1093\/annonc\/mds187_bb0025","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr1672","article-title":"Recent trends in breast cancer incidence rates by age and tumour characteristics among United States women","volume":"9","author":"Jemal","year":"2007","journal-title":"Breast Cancer Res"},{"key":"10.1093\/annonc\/mds187_bb0030","doi-asserted-by":"crossref","first-page":"b104","DOI":"10.1016\/S0140-6736(01)72307-0","article-title":"On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases","volume":"148","author":"Beatson","year":"1896","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mds187_bb0035","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mds187_bb0040","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1093\/annonc\/mds187_bb0045","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMra0801289","article-title":"Gene-expression signatures in breast cancer","volume":"360","author":"Sotiriou","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds187_bb0050","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ijc.23518","article-title":"How basal are triple-negative breast cancers?","volume":"123","author":"Bertucci","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mds187_bb0055","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/annonc\/mdm360","article-title":"Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 \u2018triple-negative\u2019 breast cancers","volume":"18","author":"Bidard","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mds187_bb0060","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1158\/1055-9965.EPI-08-0544","article-title":"Triple-negative breast cancer and obesity in a rural Appalachian population","volume":"17","author":"Vona-Davis","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mds187_bb0065","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mds187_bb0070","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.ejca.2006.08.015","article-title":"Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance","volume":"42","author":"Rakha","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mds187_bb0075","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/annonc\/mds187_bb0080","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/cncr.23243","article-title":"The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999\u20132004","volume":"112","author":"Brown","year":"2008","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds187_bb0085","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","article-title":"The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes","volume":"13","author":"Carey","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mds187_bb0090","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","article-title":"Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype","volume":"14","author":"Cheang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mds187_bb0095","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-008-9926-3","article-title":"Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA","volume":"113","author":"Lund","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1093\/annonc\/mds187_bb0100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1093\/annonc\/mds187_bb0105","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/annonc\/mds187_bb0110","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1158\/1535-7163.MCT-06-0126","article-title":"Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer","volume":"5","author":"S\u00f8rlie","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1093\/annonc\/mds187_bb0115","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/annonc\/mds187_bb0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2164-7-127","article-title":"Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms","volume":"7","author":"S\u00f8rlie","year":"2006","journal-title":"BMC Genomics"},{"key":"10.1093\/annonc\/mds187_bb0125","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1093\/annonc\/mds187_bb0130","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","article-title":"Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer","volume":"9","author":"Anders","year":"2009","journal-title":"Clin Breast Cancer"},{"key":"10.1093\/annonc\/mds187_bb0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/00313020802563510","article-title":"Triple-negative\/basal-like breast cancer: a review","volume":"41","author":"Rakha","year":"2009","journal-title":"Pathology"},{"key":"10.1093\/annonc\/mds187_bb0140","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study hrom the California Cancer Registry","volume":"109","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds187_bb0145","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/bcr2242","article-title":"Triple-negative breast cancers are increased in black women regardless of age or body mass index","volume":"11","author":"Stead","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1093\/annonc\/mds187_bb0150","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/bcr2261","article-title":"Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors","volume":"11","author":"Kwan","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1093\/annonc\/mds187_bb0155","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/bcr2780","article-title":"Lifetime risks of specific breast cancer subtypes among women in four racial\/ethnic groups","volume":"12","author":"Kurian","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1093\/annonc\/mds187_bb0160","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/cncr.25862","article-title":"Higher population-based incidence rates of triple-negative breast cancer among young African-American women: implications for breast cancer screening recommendations","volume":"117","author":"Amirikia","year":"2011","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds187_bb0165","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1200\/JCO.2008.19.6873","article-title":"Population differences in breast cancer: survey in indigenous african women reveals over-representation of triple-negative breast cancer","volume":"27","author":"Huo","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds187_bb0170","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1002\/cncr.25276","article-title":"African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study","volume":"116","author":"Stark","year":"2010","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds187_bb0175","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","article-title":"The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2","volume":"20","author":"Lakhani","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds187_bb0180","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1158\/1055-9965.EPI-08-0544","article-title":"Triple-negative breast cancer and obesity in a rural appalachian population","volume":"17","author":"Vona-Davis","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mds187_bb0185","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10552-009-9331-1","article-title":"The epidemiology of triple-negative breast cancer, including race","volume":"20","author":"Trivers","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1093\/annonc\/mds187_bb0190","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1002\/cncr.25443","article-title":"Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer","volume":"116","author":"Shinde","year":"2010","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds187_bb0195","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-08-1005","article-title":"Risk factors for triple-negative breast cancer in women under age 45","volume":"18","author":"Dolle","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mds187_bb0200","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jnci\/djr030","article-title":"Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer","volume":"103","author":"Phipps","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mds187_bb0205","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10552-011-9750-7","article-title":"Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women","volume":"22","author":"Kabat","year":"2011","journal-title":"Cancer Causes Control"},{"issue":"Suppl 4","key":"10.1093\/annonc\/mds187_bb0210","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/bcr2737","article-title":"Emerging breast cancer epidemic: evidence from Africa","volume":"12","author":"Akarolo-Anthony","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1093\/annonc\/mds187_bb0215","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2010.28.15_suppl.520","article-title":"Use of meta-analysis of gene expression profiling studies to identify biologically relevant pathways associated with aggressive breast cancer (BC) in young women","volume":"28","author":"Bedard","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds187_bb0220","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm.2000","article-title":"Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers","volume":"15","author":"Lim","year":"2009","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mds187_bb0225","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nm0809-842","article-title":"Mammary development meets cancer genomics","volume":"15","author":"Prat","year":"2009","journal-title":"Nat Med"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419376355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419376355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/suppl_6\/vi7\/6673751\/mds187.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T14:09:14Z","timestamp":1635775754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419376355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":44,"alternative-id":["S0923753419376355"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mds187","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}